SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARZOLA, Giuliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.519
AS - Asia 1.198
EU - Europa 922
SA - Sud America 151
AF - Africa 26
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.462
SG - Singapore 438
CN - Cina 352
DE - Germania 334
FI - Finlandia 165
VN - Vietnam 148
BR - Brasile 117
UA - Ucraina 105
GB - Regno Unito 99
HK - Hong Kong 65
IT - Italia 65
TR - Turchia 62
FR - Francia 44
CA - Canada 38
SE - Svezia 30
IN - India 27
JP - Giappone 22
RU - Federazione Russa 20
BD - Bangladesh 16
MX - Messico 15
PL - Polonia 13
IQ - Iraq 10
LT - Lituania 9
NL - Olanda 9
PK - Pakistan 9
UZ - Uzbekistan 9
AR - Argentina 8
ES - Italia 8
ID - Indonesia 8
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
AU - Australia 5
CL - Cile 5
EG - Egitto 5
IL - Israele 5
PY - Paraguay 5
CO - Colombia 4
MA - Marocco 4
SA - Arabia Saudita 4
TN - Tunisia 4
AL - Albania 3
BE - Belgio 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
IR - Iran 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
JO - Giordania 2
KE - Kenya 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
SN - Senegal 2
BY - Bielorussia 1
EE - Estonia 1
HN - Honduras 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 4.823
Salva come PNG Salva come JPEG
Città #
Ashburn 334
Singapore 276
Munich 250
Fairfield 226
Woodbridge 214
Houston 173
Beijing 122
San Jose 120
Jacksonville 117
Helsinki 108
Chandler 95
Ann Arbor 94
Santa Clara 92
Seattle 87
Wilmington 84
Cambridge 78
Hong Kong 63
Dallas 60
New York 51
Ho Chi Minh City 49
Los Angeles 41
Nanjing 34
Hanoi 31
Izmir 29
Shanghai 28
Turku 26
Boardman 25
San Diego 25
Milan 23
Princeton 23
Orem 22
Tokyo 21
Frankfurt am Main 18
São Paulo 18
Lauterbourg 17
Ferrara 16
The Dalles 16
London 13
Mcallen 13
Montréal 12
Bremen 11
Buffalo 11
Chennai 11
Denver 11
Montreal 11
Chicago 10
Haiphong 10
Mexico City 10
Dearborn 9
Poplar 9
Stockholm 9
Tianjin 9
Atlanta 8
Guangzhou 8
Hebei 8
Nanchang 8
Shenyang 8
Tashkent 8
Warsaw 8
Brooklyn 7
Da Nang 7
Falkenstein 7
Hefei 7
Manchester 7
Toronto 7
Amsterdam 6
Dhaka 6
Falls Church 6
Jyväskylä 6
Addison 5
Baghdad 5
Bexley 5
Changsha 5
Johannesburg 5
Mountain View 5
Norwalk 5
Philadelphia 5
Rio de Janeiro 5
San Mateo 5
Sydney 5
Tappahannock 5
Washington 5
Indiana 4
Jiaxing 4
Phoenix 4
San Francisco 4
Ardabil 3
Asunción 3
Auburn Hills 3
Barnet 3
Bologna 3
Boston 3
Brasília 3
Brussels 3
Bến Tre 3
Clifton 3
Colombo 3
Ha Long 3
Honolulu 3
Hải Dương 3
Totale 3.510
Salva come PNG Salva come JPEG
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 388
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 307
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 269
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 257
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 253
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 251
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 246
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 237
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 229
Post-ischemic recovery of acetylcholine release in vitro: influence of different excitatory amino acid receptor subtype antagonists 226
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 226
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 222
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 217
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 212
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 201
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 201
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 196
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 193
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 185
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 169
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues 2. In vivo studies 109
null 50
Totale 4.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.926
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 31 38 13
2021/2022281 6 31 33 17 18 13 12 20 9 26 25 71
2022/2023232 21 18 21 31 37 26 17 14 27 1 9 10
2023/2024183 14 15 11 7 9 58 8 13 4 1 8 35
2024/2025901 7 14 44 39 74 119 106 80 167 46 97 108
2025/20261.705 203 67 143 264 258 130 209 91 175 165 0 0
Totale 4.844